Alkermes plc and Perrigo Company plc: SG&A Spending Patterns Compared

SG&A Spending Patterns: Alkermes plc vs. Perrigo Company plc

In the ever-evolving pharmaceutical industry, understanding spending patterns is crucial for strategic planning. Over the past decade, Alkermes plc and Perrigo Company plc have demonstrated distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Alkermes plc's SG&A expenses surged by approximately 245%, reflecting a strategic expansion and investment in operational capabilities. In contrast, Perrigo Company plc maintained a more stable growth trajectory, with a 90% increase over the same period, indicating a focus on efficiency and cost management.

By 2023, Perrigo's SG&A expenses were nearly double those of Alkermes, highlighting its larger scale of operations. These insights provide a window into the strategic priorities of these companies, with Alkermes focusing on growth and Perrigo on maintaining its market position. Such financial strategies are pivotal in navigating the competitive landscape of the pharmaceutical sector.